Tower Research Capital LLC (TRC) - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 163 filers reported holding ANI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,605
-24.8%
286
-30.2%
0.00%0.0%
Q2 2023$22,070
+104995.2%
410
-20.7%
0.00%0.0%
Q1 2023$21
+75.0%
517
+78.3%
0.00%
Q4 2022$12
-100.0%
290
-89.7%
0.00%
-100.0%
Q3 2022$91,000
+600.0%
2,813
+540.8%
0.00%
Q2 2022$13,000
+116.7%
439
+108.1%
0.00%
Q1 2022$6,000
-53.8%
211
-26.0%
0.00%
Q4 2021$13,000
-58.1%
285
-69.2%
0.00%
-100.0%
Q3 2021$31,000
-46.6%
924
-44.2%
0.00%
-50.0%
Q2 2021$58,000
+205.3%
1,655
+217.7%
0.00%
Q1 2021$19,000
-38.7%
521
-51.2%
0.00%
-100.0%
Q4 2020$31,000
-87.4%
1,068
-87.8%
0.00%
-66.7%
Q3 2020$246,000
+382.4%
8,733
+445.5%
0.00%
+50.0%
Q2 2020$51,000
+59.4%
1,601
+315.8%
0.00%0.0%
Q2 2019$32,000
+190.9%
385
+53.4%
0.00%
+100.0%
Q4 2018$11,000
-59.3%
251
-50.9%
0.00%
-50.0%
Q3 2017$27,000
-10.0%
511
-15.7%
0.00%
-33.3%
Q1 2017$30,000
+500.0%
606
+630.1%
0.00%
+200.0%
Q4 2016$5,000
-90.9%
83
-89.9%
0.00%
-80.0%
Q3 2016$55,000
+323.1%
822
+267.0%
0.01%
+400.0%
Q2 2016$13,000
-88.0%
224
-91.8%
0.00%
-90.0%
Q3 2015$108,0002,7380.01%
Q4 2014$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2014$183,000
+185.9%
5,313
+158.9%
0.02%
+200.0%
Q1 2014$64,000
+3100.0%
2,052
+1931.7%
0.01%
Q4 2013$2,000
+100.0%
101
+40.3%
0.00%
Q3 2013$1,000720.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders